Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedMay 09, 2026
DataAggregated Company Financials
Companies20
  • 7D3.7%
  • 3M-3.2%
  • 1Y-29.4%
  • YTD-12.6%

In the last week, the Healthcare industry is up 3.7%, with Novo Nordisk up 4.6%. In the past year, the industry is down 29%. Looking forward, earnings are forecast to grow by 2.2% annually.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 09 May 2026DKK 1.7tDKK 467.5bDKK 148.5b20.8x11.5x3.6x
Mon, 06 Apr 2026DKK 1.5tDKK 447.8bDKK 130.1b17.4x11.3x3.3x
Wed, 04 Mar 2026DKK 1.5tDKK 448.2bDKK 131.1b17.5x11.1x3.2x
Fri, 30 Jan 2026DKK 2.1tDKK 453.2bDKK 136.7b17.5x15.6x4.7x
Sun, 28 Dec 2025DKK 2.0tDKK 453.7bDKK 136.8b17.1x14.4x4.3x
Tue, 25 Nov 2025DKK 1.8tDKK 454.3bDKK 137.1b17.4x13x3.9x
Thu, 23 Oct 2025DKK 2.0tDKK 447.8bDKK 141.8b18.9x14.4x4.5x
Sat, 20 Sep 2025DKK 2.2tDKK 447.3bDKK 141.7b19x15.7x5x
Mon, 18 Aug 2025DKK 1.9tDKK 444.4bDKK 140.2b28.1x13.6x4.3x
Wed, 16 Jul 2025DKK 2.4tDKK 423.3bDKK 124.5b29.9x19.1x5.6x
Fri, 13 Jun 2025DKK 2.8tDKK 423.4bDKK 124.6b31.2x22.4x6.6x
Sun, 11 May 2025DKK 2.4tDKK 423.4bDKK 124.9b22.6x19.4x5.7x
Tue, 08 Apr 2025DKK 2.4tDKK 409.5bDKK 121.3b21.9x19.5x5.8x
Thu, 06 Mar 2025DKK 3.3tDKK 409.9bDKK 121.4b27.7x27.4x8.1x
Sat, 01 Feb 2025DKK 3.3tDKK 387.7bDKK 111.4b28.8x29.2x8.4x
Mon, 30 Dec 2024DKK 3.4tDKK 387.4bDKK 111.3b29.9x30.1x8.7x
Wed, 27 Nov 2024DKK 3.9tDKK 387.4bDKK 111.3b31x35.2x10.1x
Fri, 25 Oct 2024DKK 4.1tDKK 372.2bDKK 107.2b33.7x38x10.9x
Sun, 22 Sep 2024DKK 4.4tDKK 371.9bDKK 107.1b37.4x40.8x11.8x
Tue, 20 Aug 2024DKK 4.7tDKK 370.7bDKK 107.0b37.4x43.8x12.6x
Thu, 18 Jul 2024DKK 4.7tDKK 355.2bDKK 106.2b35.3x43.8x13.1x
Sat, 15 Jun 2024DKK 5.0tDKK 355.3bDKK 106.2b35.5x46.7x14x
Mon, 13 May 2024DKK 4.5tDKK 354.9bDKK 106.0b34.6x42.5x12.7x
Wed, 10 Apr 2024DKK 4.4tDKK 341.2bDKK 99.6b37.3x44.2x12.9x
Fri, 08 Mar 2024DKK 4.7tDKK 341.1bDKK 99.6b38.9x47.3x13.8x
Sun, 04 Feb 2024DKK 4.0tDKK 338.6bDKK 98.5b32.7x40.6x11.8x
Tue, 02 Jan 2024DKK 3.6tDKK 320.4bDKK 90.0b32.8x40.4x11.3x
Thu, 30 Nov 2023DKK 3.6tDKK 320.5bDKK 90.0b33x39.9x11.2x
Sat, 28 Oct 2023DKK 3.4tDKK 305.6bDKK 82.3b26.6x41.5x11.2x
Mon, 25 Sep 2023DKK 3.4tDKK 305.5bDKK 82.2b33.8x41.3x11.1x
Wed, 23 Aug 2023DKK 3.4tDKK 303.7bDKK 81.3b38.4x41.4x11.1x
Fri, 21 Jul 2023DKK 3.0tDKK 287.0bDKK 75.4b40.5x39.9x10.5x
Sun, 18 Jun 2023DKK 3.0tDKK 287.1bDKK 75.5b40.5x40.3x10.6x
Tue, 16 May 2023DKK 3.2tDKK 284.8bDKK 74.9b42.4x42.7x11.2x
Price to Earnings Ratio

42.7x


Total Market Cap: DKK 3.2tTotal Earnings: DKK 74.9bTotal Revenue: DKK 284.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 30.7x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 11.5x which is lower than its 3-year average PE of 30.7x.
  • The 3-year average PS ratio of 8.8x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 26% per year over the last three years.
  • Revenues for these companies have grown 18% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market0.41%
Healthcare3.74%
Pharma4.38%
Medical Equipment2.68%
Biotech-0.61%
Healthcare Services-0.67%
Life Sciences-1.43%
Healthtech-5.71%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 618x.
    • Analysts are expecting annual earnings growth of 87.6%, which is higher than its past year's earnings decline of 99.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 88% over the next 5 years.
  • This is better than its past earnings decline of 100% per year.
  • In contrast, the Pharma industry is expected to see its earnings growth to stay flat over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVO B Novo NordiskDKK 290.754.6%
+DKK 56.1b		-34.6%PE10.6x
DEMANT DemantDKK 232.6011.3%
+DKK 5.0b		-6.9%PE20.7x
ALK B ALK-AbellóDKK 254.405.1%
+DKK 2.7b		55.2%PE44x
ZEAL Zealand PharmaDKK 342.8010.9%
+DKK 2.4b		-20.1%PE3.8x
HLUN B H. LundbeckDKK 43.141.7%
+DKK 733.5m		42.9%PE13.4x

Latest News

GMAB
DKK 1,640.00
Genmab
7D
-3.2%
1Y
24.3%
ZEAL
DKK 342.80
Zealand Pharma
7D
10.9%
1Y
-20.1%
GUBRA
DKK 322.00
Gubra
7D
0.3%
1Y
-19.3%
NOVO B
DKK 290.75
Novo Nordisk
7D
4.6%
1Y
-34.6%
AMBU B
DKK 62.45
Ambu
7D
-4.6%
1Y
-39.4%
DEMANT
DKK 232.60
Demant
7D
11.3%
1Y
-6.9%
CHEMM
DKK 315.00
ChemoMetec
7D
-3.4%
1Y
-35.7%
ALK B
DKK 254.40
ALK-Abelló
7D
5.1%
1Y
55.2%
HLUN B
DKK 43.14
H. Lundbeck
7D
1.7%
1Y
42.9%
Narrative Update • May 05

HLUN B: Late-Stage Neurology Pipeline Will Support Future Margins

Analysts have nudged their fair value estimate for H. Lundbeck stock from DKK 61.99 to DKK 63.32, reflecting updated views on revenue growth, profit margins and future P/E assumptions.
PEG
DKK 0.078
Pharma Equity Group
7D
-8.5%
1Y
-1.3%
BAVA
DKK 189.50
Bavarian Nordic
7D
0.8%
1Y
15.1%
Narrative Update • Apr 30

BAVA: Vaccine Approvals And Capacity Expansion Will Drive Future Upside

Analysts have kept their DKK 250.00 price target for Bavarian Nordic unchanged. They point to only small tweaks to assumptions on discount rate, revenue contraction, profit margin and future P/E, which they view as largely offsetting each other.
EMBLA
DKK 26.95
Embla Medical hf
7D
0.7%
1Y
-8.6%
Narrative Update • Apr 30

EMBLA: Share Cancellations And Capital Authorisations Will Support Future Upside

Analysts have trimmed their price target on Embla Medical hf. to DKK 33.30 from DKK 37.40, citing updated assumptions around a slightly higher discount rate, more moderate revenue growth of 8.40% and a lower future P/E of about 21x, while keeping profit margin expectations broadly in line.
COLO B
DKK 402.70
Coloplast
7D
-0.02%
1Y
-37.1%
BIOPOR
DKK 1.15
BioPorto
7D
-7.3%
1Y
-24.0%
VIRO
DKK 10.20
ViroGates
7D
-9.7%
1Y
53.2%
NNIT
DKK 41.65
NNIT
7D
-6.0%
1Y
-38.1%